Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1968 1
1973 2
1976 1
1979 1
1984 1
1989 2
1991 4
1992 1
1994 1
1995 1
1996 1
1999 3
2000 1
2001 3
2002 12
2003 13
2004 10
2005 5
2006 8
2007 11
2008 15
2009 14
2010 18
2011 14
2012 16
2013 9
2014 5
2015 13
2016 17
2017 17
2018 22
2019 32
2020 51
2021 43
2022 29
2023 47
2024 44
2025 46

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O'Reilly EM, Hackert T, Golan T, Prager G, Haustermans K, Vogel A, Ducreux M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Conroy T, et al. Among authors: prager g. Ann Oncol. 2023 Nov;34(11):987-1002. doi: 10.1016/j.annonc.2023.08.009. Epub 2023 Sep 9. Ann Oncol. 2023. PMID: 37678671 Free article. No abstract available.
How we treat esophageal squamous cell carcinoma.
Puhr HC, Prager GW, Ilhan-Mutlu A. Puhr HC, et al. Among authors: prager gw. ESMO Open. 2023 Feb;8(1):100789. doi: 10.1016/j.esmoop.2023.100789. Epub 2023 Feb 13. ESMO Open. 2023. PMID: 36791637 Free PMC article. Review.
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial.
Wen PY, Stein A, van den Bent M, De Greve J, Wick A, de Vos FYFL, von Bubnoff N, van Linde ME, Lai A, Prager GW, Campone M, Fasolo A, Lopez-Martin JA, Kim TM, Mason WP, Hofheinz RD, Blay JY, Cho DC, Gazzah A, Pouessel D, Yachnin J, Boran A, Burgess P, Ilankumaran P, Gasal E, Subbiah V. Wen PY, et al. Among authors: prager gw. Lancet Oncol. 2022 Jan;23(1):53-64. doi: 10.1016/S1470-2045(21)00578-7. Epub 2021 Nov 24. Lancet Oncol. 2022. PMID: 34838156 Clinical Trial.
Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO/ASMBS).
De Luca M, Shikora S, Eisenberg D, Angrisani L, Parmar C, Alqahtani A, Aminian A, Aarts E, Brown WA, Cohen RV, Di Lorenzo N, Faria SL, Goodpaster KPS, Haddad A, Herrera MF, Rosenthal R, Himpens J, Iossa A, Kermansaravi M, Kow L, Kurian M, Chiappetta S, LaMasters T, Mahawar K, Merola G, Nimeri A, O'Kane M, Papasavas PK, Piatto G, Ponce J, Prager G, Pratt JSA, Rogers AM, Salminen P, Steele KE, Suter M, Tolone S, Vitiello A, Zappa M, Kothari SN. De Luca M, et al. Among authors: prager g. Surg Obes Relat Dis. 2024 Nov;20(11):991-1025. doi: 10.1016/j.soard.2024.05.009. Epub 2024 Jun 11. Surg Obes Relat Dis. 2024. PMID: 39419572 Free article. Review.
Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement.
Haddad A, Suter M, Greve JW, Shikora S, Prager G, Dayyeh BA, Galvao M, Grothe K, Herrera M, Kow L, Le Roux C, O'Kane M, Parmar C, Quadros LG, Ramos A, Vidal J, Cohen RV. Haddad A, et al. Among authors: prager g. Obes Surg. 2024 Nov;34(11):3944-3962. doi: 10.1007/s11695-024-07489-7. Epub 2024 Oct 14. Obes Surg. 2024. PMID: 39400870 Review.
Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS).
De Luca M, Shikora S, Eisenberg D, Angrisani L, Parmar C, Alqahtani A, Aminian A, Aarts E, Brown W, Cohen RV, Di Lorenzo N, Faria SL, Goodpaster KPS, Haddad A, Herrera M, Rosenthal R, Himpens J, Iossa A, Kermansaravi M, Kow L, Kurian M, Chiappetta S, LaMasters T, Mahawar K, Merola G, Nimeri A, O'Kane M, Papasavas P, Piatto G, Ponce J, Prager G, Pratt JSA, Rogers AM, Salminen P, Steele KE, Suter M, Tolone S, Vitiello A, Zappa M, Kothari SN. De Luca M, et al. Among authors: prager g. Obes Surg. 2024 Nov;34(11):3963-4096. doi: 10.1007/s11695-024-07370-7. Epub 2024 Sep 25. Obes Surg. 2024. PMID: 39320627 Free PMC article.
482 results